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Abstract
Background: The association between cerebral palsy in very preterm infants and clinical,
histopathologic and microbiological indicators of chorioamnionitis, including the identification of
specific micro-organisms in the placenta, was evaluated in a case-cohort study.
Methods: Children with a diagnosis of cerebral palsy at five years of age were identified from
amongst participants in a long-term follow-up program of preterm infants. The comparison group
was a subcohort of infants randomly selected from all infants enrolled in the program. The
placentas were examined histopathologically for chorioamnionitis and funisitis, and the
chorioamnionic interface was aseptically swabbed and comprehensively cultured for aerobic and
anaerobic bacteria, yeast and genital mycoplasmas. Associations between obstetric and
demographic variables, indicators of chorioamnionitis and cerebral palsy status were examined by
univariate analysis.
Results: Eighty-two infants with cerebral palsy were compared with the subcohort of 207 infants.
Threatened preterm labor was nearly twice as common among the cases as in the subcohort (p <
0.01). Recorded clinical choroamnionitis was similar in the two groups and there was no difference
in histopathologic evidence of infection between the two groups. E. coli was cultured from the
placenta in 6/30 (20%) of cases as compared with 4/85 (5%) of subcohort (p = 0.01). Group B
Streptococcus was more frequent among the cases, but the difference was not statistically
significant.
Conclusions: The association between E. coli in the chorioamnion and cerebral palsy in preterm
infants identified in this study requires confirmation in larger multicenter studies which include
microbiological study of placentas.
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The rate of cerebral palsy amongst neonatal survivors
born below 33 weeks is up to 30 times higher than among
those born at term [1,2]. The etiology of this condition is
poorly understood and current research focuses on the
prenatal period. A number of epidemiologic studies have
reported a relationship between maternal clinical chorio-
amnionitis and neurologic damage among very low birth-
weight infants [3-10]. This correlation is corroborated by
experimental data [11].
Although most prior studies have used non-specific clini-
cal measures of chorioamnionitis to provide retrospective
information on infection [7], studies linking histopatho-
logic indicators of chorioamnionitis with cerebral palsy
point to infection of the chorioamnion as a potential
cause. Investigations into the etiology of cerebral palsy
among surviving very preterm infants have rarely exam-
ined the microbiology of the chorioamnion. Knowledge
of the specific microorganisms involved is essential before
preventive strategies such as screening and treatment of
infection during pregnancy can be developed. This study
examines clinical, histopathologic and microbiological
indicators of chorioamnionitis, including the identifica-
tion of specific micro-organisms in the placenta as risk fac-
tors for cerebral palsy among preterm infants.
Methods
A case-cohort study was conducted using the Women's
and Children's Hospital (Adelaide, Australia) long-term
follow-up program for the years 1984 to 1994. The case-
cohort study design provides the advantages of a cohort
study in that it allows the direct calculation of a risk ratio
without either a rare disease assumption or, as in this case,
the collection of full information on every member of a
cohort. All cases of the condition of interest that arise
within a defined cohort comprise the case group. Their
exposure experience is compared with that of a randomly
selected subset of the entire cohort. Thus exposure data in
this study were ascertained on all cases of cerebral palsy
and a subset of all preterm infants enrolled in the long-
term follow-up program. The case-cohort study design
allows for the efficient investigation of all cases of cerebral
palsy within the target cohort and a sample of infants
enrolled in the longterm follow-up program, without los-
ing the advantage provided by the direct measurement of
risk of cerebral palsy associated with placental infection,
which would be assessed in a cohort study [12].
Pre-term infants are registered in the long-term follow-up
program by hospital staff. Criteria for registration have
changed over time; infants registered prior to 1992 had
birthweights ≤ 1500 grams. After 1992, only infants born
at ≤ 29 weeks gestation or ≤ 1000 grams were eligible for
long-term follow-up. This study only included infants
enrolled in the program between 1984 and 1994 to
ensure that sufficient calendar time had elapsed for all of
them to undergo neuro-developmental assessment at five
years of age.
Cerebral palsy was determined by assessment by a paedi-
atrician and physiotherapist with expertise in neuro-
development. In the Long-Term Follow-Up Unit, cerebral
palsy is defined as disorder of movement and posture
occurring due to central problems of the brain and is of
early childhood onset; there should be some objective
motor signs present – such as alteration of muscle tone,
deep tendon reflexes or persistent puncture reflexes, alter-
ation of balance and control and, in some individuals,
presence of involuntary movements; other progressive
neuromuscular disorders or insult to the brain that was
acquired after 2 years of age were excluded. Every child
diagnosed by neuro-developmental assessment at five
years of age as having cerebral palsy and for whom ante-
natal data were available, was included as a case. If there
was no diagnosis at 5 years of age, then a diagnosis of
moderate or severe cerebral palsy at either three or four
years of age was accepted. If a diagnosis was made at two
years of age or less that was not confirmed at a later age,
the child was not included as a case. Any child with a diag-
nosis of minimal cerebral palsy was excluded. Of 143
originally identified on the database we excluded children
with a minimal diagnosis, two who were adopted, 12
retrievals who had no antenatal data, and 20 with a diag-
nosis of mild CP before 24 months of age that was not
confirmed subsequently and two who were syndromic.
The comparison group was a subcohort randomly selected
from the long term follow-up data base regardless of case
status and covariate status and with antenatal data availa-
ble (24 cases were also included in the sub-cohort). A ran-
dom sample generator in Microsoft Excel was used to
generate the subcohort selecting based on unit record
number, which is a unique identifier for each infant. The
subcohort was selected to represent the distribution of
infants entered onto the Growth and Development Unit
database under the two different admission criteria. A
total of 1207 infants were admitted to the Growth and
Development Program at the Women's and Children's
Hospital between 1984 and 1994. Between 1984 and
1991, 920 (76%) infants were admitted to the Long Term
Follow-Up Program under the selection criterion of
weighing <1500 g at birth. Between 1992 and 1994, 287
(24%) infants were admitted to the Growth and Develop-
ment Unit under the selection criteria of ≤ 29 weeks gesta-
tional age or <1000 g at birth. Of the 240 infants selected
for the subcohort, 182 (76%) were born between 1984
and 1991, while 58 (24%) were born between 1992 and
1994. Following the exclusion of children who werePage 2 of 7
(page number not for citation purposes)
BMC Pregnancy and Childbirth 2004, 4 http://www.biomedcentral.com/1471-2393/4/1adopted and those who were transferred in, 207 infants
were available for analysis.
Demographic, obstetric and laboratory data were col-
lected from case note review and hospital databases.
Obstetric data included threatened preterm labor which is
defined as preterm labor that is subsequently suppressed
and does not result in delivery. Placental swabs for micro-
biology were obtained aseptically by histopathology staff
from the chorioamnionic membrane interface from 30
cases and 85 subcohort, and cultured for aerobic and
anaerobic bacteria, yeasts and genital mycoplasmas,
according to hospital guidelines which specified that pla-
centas from gestations less than 34 weeks should be sub-
mitted for pathological examination [13,14]. Placental
examination was performed in 54 (65%) cases and 150
(72%) subcohort. These slides were reviewed in 2001 by
a histopathologist blinded to the cerebral palsy outcome
and acute chorioamnionitis and funisitis were diagnosed
using standard criteria [15].
Univariate analyses were undertaken examining associa-
tions between obstetric and demographic characteristics,
clinical, histopathologic and microbiological indicators
of chorioamnionitis and cerebral palsy status. Results of
multivariable analyses are not presented. Given the com-
plexity of causal pathways to cerebral palsy involving pre-
term birth [16], we considered it inappropriate to adjust
(other than by stratified sampling), for gestation, which
may be both an independent cause of cerebral palsy and
on the pathway from infection to cerebral palsy.
Results
Eighty two infants with cerebral palsy (25 with quadriple-
gia, 14 with hemiplegia, 31 with diplegia, 2 with mono-
plegia, 10 other types) were compared with the subcohort
of 207 infants. Eighty five percent of the infants with cer-
ebral palsy and eighty four percent of infants in the com-
parison sub-cohort entered the follow-up database prior
to 1992. The demographic and obstetric characteristics of
the study population are shown in Table 1. Over one
quarter of infants was of multiple gestation. Threatened
preterm labor was nearly twice as common among the
cases as in the subcohort (p ≤ 0.01). Preterm prelabor rup-
ture of membranes, which carries an increased risk of
infection, was frequent in both cases and subcohort.
Table 1: Demographic and obstetric characteristics of study population
CHARACTERISTICS Cases n (%) Sub-Cohort n (%) Relative risk (95% 
Confidence Intervals)
P value
Total 82 207
Obstetric Factors
Primigravida 27 (33%) 81 (39%) 0.81 [0.55, 1.19] 0.29
Threatened preterm labor 15 (18%) 18 (9%) 1.82 [1.21, 2.73] < 0.01
Pre-eclampsia 8 (10%) 30 (14%) 0.69 [0.36, 1.30] 0.25
Severe intra-uterine growth restriction (as 
in casenotes)
13 (16%) 32 (16%) 1.00 [0.61, 1.64] 1.00
Placental abruption 11 (13%) 19 (9%) 1.37 [0.83, 2.24] 0.22
Preterm prelabor rupture of the 
membranes
32 (39%) 79 (38%) 1.02 [0.71, 1.48] 0.90
Placenta previa 6 (7%) 8 (4%) 1.53 [0.83, 2.83] 0.18
Preterm labor 37 (45%) 94 (45%) 1.04 [0.72, 1.49] 0.83
Mode of delivery
Normal vaginal delivery 25 (30%) 56 (27%) 1.00 0.37
Cesarean section 47 (57%) 129 (62%) 0.83 [0.56, 1.24]
Forceps/Breech 10 (12%) 22 (11%) 1.08 [0.60, 1.94] 0.79
Neonatal Factors
Gestational age at delivery
≤ 27 weeks 28 (34%) 54 (26%) 1.87 [0.94, 3.70] 0.07
28–31 weeks 46 (56%) 121 (58%) 1.47 [0.75, 2.85] 0.26
≥ 32 weeks 8 (10%) 32 (16%) 1.00
Gestational age at delivery weeks, median 
(inter-quartile range)
29 (27–30) 29 (27–31) 0.93 [0.86, 1.00]a 0.06
Birthweight, grams, median (inter-quartile 
range)
1100 (880–1290) 1170 (970–1350) 0.93 [0.87, 0.99]b 0.03
Multiple gestation 18 (22%) 58 (28%) 0.77 [0.49, 1.20] 0.25
Male gender 48 (59%) 104 (50%) 1.30 [0.90, 1.89] 0.16
a Relative risk for gestational age at delivery is for a 1 week increase b Relative risk for birthweight is for a 100 g increasePage 3 of 7
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rioamnionitis are shown in Table 2. The incidence of both
neonatal sepsis and elevated maternal C-reactive protein
was higher among the cases. Placental histopathology was
performed on 65% of cases and 73% of the subcohort
while microbiology was available in 37% and 41% respec-
tively. There was no difference in histopathologic evi-
dence of infection between the two groups. Where
microbiological examinations were performed, placental
cultures were positive in 37% of cases and in 35% of the
subcohort. Overall placental culture was positive in 54%
where histological chorioamnionitis was present and 23%
where it was absent. Although the percentage of chorio-
amnions with positive culture was similar between cases
and subcohort, the types of microorganisms isolated from
cases and subcohort members differed significantly. The
most common chorioamnion isolate, Escherichia coli, was
found in 20% of cases compared with 5% of the subco-
hort (p = 0.01). Other micro-organisms prevalent in the
cerebral palsy cases are listed in Table 2. Group B Strepto-
coccus (GBS), the most common cause of early onset neo-
natal sepsis, was more frequent among cerebral palsy
cases but the excess was not statistically significant. How-
ever, in the four cases with placental GBS, two also had E.
coli, whereas in the five subcohort infants, only one had
both GBS and E. coli. This study is underpowered, how-
ever, to identify small increases in risk for specific micro-
organisms. Among the mothers with E. coli in the chorio-
amnion, clinical chorioamnionitis was found in one of six
cases and none of four subcohort, and histological chori-
oamnionitis in two of four and one of two infants, respec-
tively. Neonatal sepsis due to E. coli occurred in four
infants, two cases and two subcohort.
Discussion
Our investigation explored the relationship between
micro-organisms in the chorioamnion and cerebral palsy
in survivors of preterm birth. This strategy provides the
next step in identifying the causative pathway between
infection and cerebral palsy. A previous report [17] of six
children with cerebral palsy showed an association, that
was not confirmed by our study, between coagulase nega-
tive staphylococci in the chorioamnion space and cerebral
palsy. Of interest, in that study E. coli was isolated in the
chorioamnion of 2/5 (40%) cerebral palsy cases com-
pared with 12/102 (11.8%) controls; when we reanalysed
their data we found an Odds Ratio of 5.00 (95%CI [0.37,
47.36] p = 0.13).
The strength of this study is the investigation for specific
micro-organisms in the chorioamnion using aseptic tech-
nique by trained scientists as part of routine hospital man-
agement of preterm births. Two important aspects of our
study are: 1) the aseptic sampling method used to swab
Table 2: Indicators of chorioamnionitis: clinical, histologic and microbiological
Cases Sub-Cohort Relative risk (95% 
Confidence Intervals)
P value
Clinical indicators n = 82 n = 207
Recorded clinical chorioamnionitis 10 (12%) 27 (13%) 0.94 [0.54, 1.64] 0.84
Maternal fevera 21 (26%) 40 (19%) 1.26 [0.84, 1.87] 0.26
Uterine tenderness 13 (16%) 30 (14%) 1.13 [0.69, 1.82] 0.63
Maternal tachycardia 15 (18%) 49 (24%) 0.78 [0.48, 1.26] 0.31
Fetal tachycardia 11 (13%) 33 (16%) 0.87 [0.51, 1.49] 0.62
Elevated maternal C-reactive protein 
(>6 mg/L) /no. tested
29 /38 (76%) 49 /78 (63%) 1.75 [0.93, 3.30] 0.08
Abnormal maternal whiteblood count 
>15,000 × 106/L/no. tested
55 /70 (79%) 114 /159 (72%) 1.37 [0.85, 2.23] 0.20
Neonatal sepsis 18 (22%) 30 (14%) 1.45 [0.97, 2.18] 0.07
Placental Microbiology n = 30 n = 85
One or more isolates 11(37%) 30 (35%) 1.05 [0.56, 1.96] 0.88
Group B Streptococcus 4 (13%) 5 (6%) 1.85 [0.86, 3.97] 0.12
Escherichia coli 6 (20%) 4 (5%) 2.35 [1.27, 4.34] 0.01
Bacteroides/Prevotella spp. 3 (10%) 5 (6%) 1.54 [0.62, 3.84] 0.35
Ureaplasma spp. 3 (10%) 14 (16%) 0.66 [0.23, 1.90] 0.44
Other isolates 4 (13%) 15 (18%) 0.79 [0.32, 1.97] 0.61
Placental histopathology
Chorioamnionitis n = 54 n = 150
22 (41%) 56 (37%) 1.19 [0.76, 1.88) 0.45
Funisitis n = 54 n = 144
14 (26%) 31 (22%) 1.35 [0.83, 2.21] 0.23
a >37.5°C on two consecutive occasionsPage 4 of 7
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noted that if the maternal placental surface, instead of the
sub-amnion, is swabbed, vaginal micro-organisms which
contaminate the surface during removal, will be recov-
ered; 2) the comprehensive microbiological culture meth-
ods used to recover aerobic and anaerobic bacteria, yeasts
and genital mycoplasmas. These are costly and time-con-
suming but provide valuable information not obtainable
in other ways. Furthermore, the study involved detailed
five-year follow up of very low birthweight infants with
near complete case ascertainment.
Some limitations of this study include: retrospective
review of data collected for clinical management over a
long period; lack of information about antenatal and
postnatal steroid therapy; and lack of placental data on
some subjects, which reduced the effective sample size for
microbiological analysis to 30 cases and 85 subcohort.
These data were available on a similar proportion of cases
and the comparison sub-cohort. Although our hospital
guidelines for the submission of placentas for pathologi-
cal examination specify all placentas less than 34 weeks
should be examined, for a variety of reasons, only a pro-
portion of those placentas that meet the criteria for exam-
ination are actually submitted [18], a problem that is not
unique to our institution [19-21]. Microbiological exami-
nation was not usually performed where there was a com-
pelling reason for the preterm delivery, such as severe
early onset pre-eclampsia. Nonetheless, it is possible that
with a substantial level of missing data, a bias may have
been introduced in the comparison of microbiological
profiles between cases and the subcohort. Such bias could
be responsible for the different associations observed
between the small studies published to date. The 25%
positive culture rate from placentas without histochorio-
amnionitis is similar to other studies with comprehensive
culture including genital mycoplasmas. Hillier et al found
higher culture positive rates in preterm women (44%)
than term women without histological chorioamnionitis
(13%)[22]. Two previous reports [23,24] found 12% and
15% positive respectively but did not perform culture for
genital mycoplasmas. In addition 29% of the latter study
were at term. This study, nevertheless, has a number larger
than most previously reported studies in such a popula-
tion [7].
The strong association between threatened preterm labor
and cerebral palsy is important to note and may have sig-
nificant ramifications for obstetric management of threat-
ened preterm labor. We postulate women with threatened
preterm labour who do not deliver within a proximate
time may be at significant risk of delivering an infant with
cerebral palsy, perhaps through continuing fetal exposure
to infection or activation of cytokines involved in the
labor process.
In our study the presence of E. coli in the chorioamnion
was significantly associated with cerebral palsy. This link
is supported by experimental studies in a rabbit model,
which showed that white matter damage in the fetal brain
can be induced by E. coli amnionitis [11]. Histological
chorioamnionitis was found in two of four (50%) cases
and one of two (50%) subcohort with E. coli in the chori-
oamnion compared with 20/50 (40%) and 55/149 (37%)
respectively in E. coli negative chorioamnions but this dif-
ference was not significant. However, histological chorio-
amnionitis may sometimes be absent and varies with the
intensity and duration of infection [25].
In the light of the recent hypothesis [26] that bacterial
vaginosis is associated with cerebral palsy, we analysed
the data for Bacteroides spp. Although Bacteroides spp. were
more common among cerebral palsy cases, this was not
statistically significant. Although Ureaplasma spp. are gen-
erally the most common placental isolates found in chor-
ioamnionitis, in our study Ureaplasma spp. were not more
frequent among cerebral palsy cases. A recent study [27]
linked U. urealyticum in placentas with chorioamnionitis
and fetal vasculitis, but not in VLBW infants with cerebral
echolucencies. This suggests that other organisms, such as
E. coli, may be more important and that the reason histo-
logic chorioamnionitis itself does not directly predict
brain injury is because much of it is caused by U. urealyti-
cum. Group B Streptococcus in the chorioamnion was
twice as common in cases as in the subcohort; however,
the long-standing hospital protocol of antibiotic prophy-
laxis in labor for group B Streptococcal carriers may have
contributed to the lower total number of group B Strepto-
coccal placental isolates.
In a study of 2646 women in labor, vaginal colonisation
with E. coli was associated with preterm delivery and low
birthweight [28]. These findings, together with our data
linking E. coli and cerebral palsy, suggest the need for
investigation and identification of E. coli in the genital
tract in women with threatened preterm labor. The bene-
fits and disadvantages of antibiotic therapy should then
be considered.
Conclusions
This report of chorioamnionic E. coli infection in cerebral
palsy cases gives insight into pathogenesis of infection
and cerebral palsy and indicates the value of microbio-
logical study of placentas in extremely preterm deliveries.
Confirmation of our findings in a large prospective multi-
center study is essential considering that this vital infor-
mation may elucidate understanding of causative
pathways for cerebral palsy.
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